Literature DB >> 3415366

Normal cardiovascular autonomic function in patients with systemic sclerosis (CREST variant).

M E Suarez-Almazor1, E Bruera, A S Russell.   

Abstract

Sixteen consecutive patients with systemic sclerosis (CREST variant (calcinosis, Raynaud's phenomenon, oesophageal dysmotility, sclerodactyly, telangiectasia)) were included in this study. Standard non-invasive clinical and electrocardiographic procedures for the detection of cardiovascular autonomic insufficiency were performed in all patients and included heart rate (HR) response to deep breathing, Valsalva manoeuvre, and standing, and blood pressure (BP) response to hand grip and standing. None of the patients had overt cardiovascular disease or were receiving cardiovascular treatment at the time of testing. Results were compared with those obtained in 17 controls. A significant difference between patients and controls was observed only in the HR and BP response to standing (results of this last procedure were within the normal expected values in both patients and controls). We conclude that patients with systemic sclerosis and CREST syndrome may have an abnormal vascular response to standing; cardiovascular autonomic insufficiency, however, does not appear to be a significant feature in these patients.

Entities:  

Mesh:

Year:  1988        PMID: 3415366      PMCID: PMC1006720          DOI: 10.1136/ard.47.8.672

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

Review 1.  Autonomic insufficiency.

Authors:  W L Henrich
Journal:  Arch Intern Med       Date:  1982-02

2.  Cardiac denervation in diabetic neuropathy.

Authors:  P J Watkins; J D Mackay
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

3.  Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications.

Authors:  D J Ewing; I W Campbell; B F Clarke
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

Review 4.  Testing for autonomic neuropathy.

Authors:  J Hilsted
Journal:  Ann Clin Res       Date:  1984

5.  Study of cardiovascular autonomic insufficiency in advanced cancer patients.

Authors:  E Bruera; S Chadwick; R Fox; J Hanson; N MacDonald
Journal:  Cancer Treat Rep       Date:  1986-12

6.  Autonomic nerve function in rheumatoid arthritis of varying severity.

Authors:  I Leden; A Eriksson; B Lilja; G Sturfelt; G Sundkvist
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

  6 in total
  5 in total

1.  [Cardiovascular and pupillary autonomic and somatosensory neuropathy in chronic diseases with autoimmune phenomena. A comparative study of patients with Crohn disease, ulcerative colitis, systemic lupus erythematosus, progressive systemic sclerosis and type I diabetes mellitus].

Authors:  R H Straub; T Andus; G Lock; M Zeuner; K D Palitzsch; V Gross; B Lang; J Schölmerich
Journal:  Med Klin (Munich)       Date:  1997-11-15

2.  Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients.

Authors:  Francesco Masini; Raffaele Galiero; Pia Clara Pafundi; Klodian Gjeloshi; Emanuele Pinotti; Roberta Ferrara; Ciro Romano; Luigi Elio Adinolfi; Ferdinando Carlo Sasso; Giovanna Cuomo
Journal:  J Scleroderma Relat Disord       Date:  2021-06-07

3.  Cardiac repolarization abnormalities and increased sympathetic activity in scleroderma.

Authors:  Orcun Ciftci; Ahmet Mesut Onat; Bunyamin Yavuz; Ali Akdogan; Kudret Aytemir; Lale Tokgozoglu; Levent Sahiner; Ali Deniz; Kemal Ureten; Guler Kizilca; Meral Calguneri; Ali Oto
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

Review 4.  The autonomic nervous system in systemic sclerosis. A review.

Authors:  Luca Bertinotti; Stefania Bracci; Francesca Nacci; Nicola Colangelo; Angela Del Rosso; Roberto Casale; Alberto Pignone; Marco Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2003-12-10       Impact factor: 2.980

5.  Abnormalities of heart rate turbulence and heart rate variability as indicators of increased cardiovascular risk in patients with systemic sclerosis.

Authors:  Adam R Poliwczak; Elżbieta Waszczykowska; Bożena Dziankowska-Bartkowiak; Katarzyna Dworniak-Pryca
Journal:  Postepy Dermatol Alergol       Date:  2019-02-26       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.